The chemokine and its pathway to mediate the accumulation of regulatory T cell in human and mouse pancreatic cancer
- Author:
- No author available
- Journal Title:
- Chinese Journal of Pancreatology
- Issue:
- 5
- DOI:
- 10.3760/cma.j.issn.1674-1935.2015.05.010
- Key Word:
- 胰腺肿瘤;调节性T细胞;FOXP3;趋化因子;Pancreatic neoplasms;Regulatory T cell;FOXP3;Chemokime
Abstract： Objective To confirm the main pathway of chemokine-chemokine receptor which mediates the accumulation of regulatory T cell ( Treg) in pancreatic cancer .Methods The concentrations of protein of FOXP3 and chemokines of CCL2, CCL3, CCL5, CCL17, CXCL8 in human and mouse pancreatic cancer and adjacent normal pancreatic tissue were measured by the method of enzyme-linked immunosorbent assay (ELISA).The receptor of chemokine CCL5 (CCR5) in human and mouse pancreatic cancer were determined by the immunofluorescent stain .Results The concentration of FOXP 3 protein in human pancreatic cancer and adjacent normal pancreatic tissue as (487.5 ±534.1) and (162.6 ±42.0) pg/mg, respectively, while they were (84.6 ±54.1) and (14.4 ±7.6) pg/mg, respectively in mouse.The concentration of FOXP3 protein were significantly higher in pancreatic cancer than those in adjacent normal pancreatic tissue .The concentration of CCL2 in human pancreatic cancer and adjacent normal pancreatic tissue as (76.9 ±37.5), (40.8 ±25.5) pg/mg, and the concentration of CCL3 as (38.0 ±22.6), (21.3 ±16.5) pg/mg, and the concentration of CCL5 were (390.2 ±158.5), (59.1 ±22.8) pg/mg, and the concentration of CCL17 as (7.2 ±2.0), (4.1 ±2.4)pg/mg, and the concentration of CXCL8 as (9.3 ±5.5), (6.3 ±5.2)pg/mg.The concentration of CCL2, CCL5, CCL17 in pancreatic cancer was significantly higher than those in adjacent normal pancreatic tissue (P<0.05).The concentration of CCL2 in mouse pancreatic cancer and adjacent normal pancreatic tissue as (77.9 ±30.5), (43.6 ±16.6) pg/mg, and the concentration of CCL3 was (27.4 ±18.2), (14.0 ±4.5)pg/mg, and the concentration of CCL5 was (302.2 ±55.8), (64.5 ±30.3) pg/mg; and the concentration of CCL17 was (4.4 ±1.4), (2.2 ±1.0)pg/mg;and the concentration of CXCL8 was (55.1 ± 55.1), ( 93.4 ±7.3 ) pg/mg.The concentration of CCL2, CCL5, CCL17 in pancreatic cancer were significantly higher than those in adjacent normal pancreatic tissue , and the difference between the two groups was statistically significant (P<0.05).The level of FOXP3 in pancreatic cancer was positively correlated with the concentration of chemokine CCL 5 both in human and mouse pancreatic cancer .Immunofluorescent staining indicated that the FOXP3 +cells also expressed CCR5.Conclusions The CCL5-CCR5 is the main chemokine-chemokine receptor pathway mediating the accumulation of Treg cells in pancreatic cancer .
- [1]Coukos,G.,Facciabene,A.,Motz,G.T..T-Regulatory cells: Key players in tumor immune escape and angiogenesis[J].2012,72(9).
- [2]Steven Z Josefowicz,Li-Fan Lu,Alexander Y Rudensky.Regulatory T cells: mechanisms of differentiation and function.[J].2012,30.
- [3]Fontenot JD,Gavin MA,Rudensky AY.Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.[J].2003,4(4).
- [4]Yong-Jian Jiang,Chong-Lek Lee,Qiang Wang,etc.Establishment of an orthotopic pancreatic cancer mouse model: Cells suspended and injected in Matrigel[J].2014,(28).
- [5]Shibuya, Kendall C.,Goel, Vikas K.,Xiong, Wei,etc.Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment.[J].2014,9(5).
- [6]Buist N,Levy-Lahad E,Proll S,etc.X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.[J].2001,27(1).
- [7]Shohei, Hori,Takashi, Nomura,Shimon, Sakaguchi.Control of regulatory T cell development by the transcription factor Foxp3.[J].2003,299(5609).
- [8]Sakaguchi N,Asano M,Sakaguchi S,etc.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.[J].1995,155(3).
- [9]Tang, Yichen,Xu, Xuejun,Guo, Shixiang.An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma.[J].2014,9(3).
- [10]Kawaguchi Y,Akaike H,Kono K,etc.CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.[J].2008,122(10).
- [11]Dimitrios, Mougiakakos,Aniruddha, Choudhury,Alvaro, Lladser,etc.Regulatory T cells in cancer.[J].2010,107.
- [12]Hiraoka,N,Onozato,K,Kosuge,T,etc.Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.[J].2006,12(18).
- [13].Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer[J].2013,108(4).
- [14]Michael H. Kershaw,Matthew D. Vesely,Robert D. Schreiber,etc.Natural Innate and Adaptive Immunity to Cancer[J].2011,29.
- [15]Kelly TE,Chance PF,Christie J,etc.The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.[J].2001,27(1).
- [16]Tan MC,Belt BA,Goedegebuure PS,etc.Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer.[J].2009,182(3).
- [17]Miller AM,Banham AH,Lundberg K,etc.CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients.[J].2006,177(10).
- [18]Blay JY,Perez S,Goddard Leon S,etc.Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.[J].2009,69(5).
- [19]Imura S,Shimada M,Yamaguchi T,etc.Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients.[J].2006,33(4).
- [20]Curiel TJ,Knutson KL,Daniel B,etc.Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.[J].2004,10(9).
- [21]Carolyn E,Clark.Dynamics of the immune reaction to pancreatic cancer from inception to invasion.[J].2007,67.